Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
Auto Casualty
Podcast
Combatting New Jersey Auto Casualty Challenges
Mitchell
Article
Plugged-In: EV Collision Insights 2023 Year in Review
Mitchell
News Release
Latest Mitchell Data Shows Continued Increase in Electric Vehicle Collision Claims
The frequency of claims submitted for repairable electric vehicles (EVs) rose to its highest level in 2023, ending the year at 1.97% in the U.S
Workers' Comp
Article
Enhancing Provider Networks: Coventry's Quality Improvement Program
Coventry's Network Quality Improvement Program is comprehensive, systematic, on-going, and compliant with provider network regulations.
Workers' Comp
In the News
Rising PTSD claims, wider comp liabilities spotlight importance of treatment guidelines
Workers' Comp
News Release
Enlyte and Former Genex Leaders Reach Agreement to Create New IME Business
SAN DIEGO, Calif.—Enlyte and its Board of Directors have made the strategic decision to transfer its Independent Medical Examination (IME) b